Switching from intravenous to subcutaneous infliximab and vedolizumab in patients with inflammatory bowel disease: impact on trough levels, day hospital visits, and medical expenses. November 25, 2023 [MEDLINE Abstract] Microbial exposure during early life regulates development of bile duct inflammation. ...